Jaleel Shujath's profile
What I do
I bring new interferon products to the life sciences market
Affiliations
Current affiliations
-
- Position
- Marketing Director
- Company
- PBL InterferonSource
- Further information
Location
- City:
- None chosen
- Hub:
- None chosen
Interests
I also enjoy keeping up with various areas of research and technology, particularly cancer, high content screening, wound healing.
Projects
Currently working on New Product Launches and the Interferon Force comic book.
Publications
-
Papetti M, Shujath J, Riley K, Herman I. FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways. Investigative ophthalmology & visual science (11) , 4994-5005 PubMed ID:(14578427)
-
Wilhelm S, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post L, Bollag G, Trail P. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer research (19) , 7099-109 PubMed ID:(15466206)
Contact
- email:
- nizami [ at ] gmail.com
- MSN:
- jshujath
- Skype:
- jshujath
- Yahoo:
- nizami.rm
Jaleel Shujath's activity on Nature Network
Entries
There are no recent entries from Jaleel Shujath.
Network
Jaleel Shujath's network is currently empty.